Cavernous cerebral infarction generally does not need stenting, but only needs to be treated by drug thrombolysis, anti-platelet aggregation, neuroprotection, dehydration and lowering of cranial pressure. Cavernous cerebral infarction is a kind of cerebral infarction caused by ischemic microinfarction foci, and the treatment should be active protective treatment for the damaged brain tissues, in addition to airway support, lowering blood pressure, correcting electrolyte disorders and so on. For patients who can be thrombolyzed, recombinant tissue-type fibrinogen activator can be used for thrombolytic therapy, while other patients can be treated with antiplatelet aggregation therapy using antiplatelet aspirin and clopidogrel, and neuroprotective therapy using idaravone and cytarabine. Cavernous cerebral infarction generally heals well and has a low lethality and disability rate, but has a high recurrence rate and generally does not require stenting.